Work

Mitoxantrone, Etoposide, and Cytarabine (MEC) Following Epigenetic Priming with Decitabine in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS): Final Results from a Phase 1/2 Study

Year: 2016

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v128.22.1064.1064

Authors: Anna B. Halpern, Sarah A. Buckley, Megan Othus, Emily M Huebner, Kaysey F. Orlowski, Bart L Scott, Andrea M. Perdue, Heather A. Smith, Pamela S. Becker, Paul C. Hendrie, Stephanie Cassone, Tara L. Chen, Derek L. Stirewalt, Elihu H. Estey, Roland B. Walter

Institutions: University of Washington, Fred Hutch Cancer Center, Seattle Cancer Care Alliance, University of Washington Medical Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4205377346

FWCI:

Cites:

Cited by:

Related to: 10